Skip to Content

'
Anuja Jhingran, M.D., FACR

Present Title & Affiliation

Primary Appointment

Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Bio Statement

Dr. Anuja Jhingran earned her M.D. at Texas Tech University in 1988, followed by residency training at Baylor College of Medicine in Internal Medicine and Radiation Oncology.  She began her career as an Assistant Professor at The University of Texas MD Anderson Cancer Center in 1996 and has grown and advanced to Professor of Radiation Oncology in the Section of Gynecology.  She is a physician specializing in the treatment of gynecologic cancers.  Clinically, she is interested in the management of advanced ovarian, cervical, and endometrial cancers and the use of advanced radiation techniques to minimize toxicity.  In addition, Dr. Jhingran is heavily involved with the Radiation Therapy Oncology Group (RTOG) and Gynecologic Oncology Group (GOG), in the development of patient care studies to treat gynecologic cancers and has been the national Principal Investigator of several studies, including a phase III study in cervical cancer.  Dr. Jhingran is also an active member of the Gynecologic Cancer InterGroup.  Dr. Jhingran travels extensively internationally for cancer education.  She is passionate about women's health issues and especially as it relates to developing country's efforts to establish improved healthcare for the general populace, not just the financially able.


Education & Training

Degree-Granting Education

1988 Texas Tech University, Health Science Center, Lubbock, TX, MD, Medicine
1984 Smith College, North Hampton, MA, BA, Biochemistry

Postgraduate Training

7/1992-6/1993 Chief Resident Department of Radiation Oncology, Radiation Oncology, Baylor College of Medicine, Houston, TX, Shiao Woo, M.D.
7/1989-6/1993 Residency Department of Radiation Oncology, Radiation Oncology, Baylor College of Medicine, Houston, TX, Shiao Woo, M.D.
7/1988-6/1989 Internal Medicine, Baylor College of Medicine, Houston, TX, Edward Lynch, M.D.

Board Certifications

1993 American Board of Radiology-Radiation Oncology

Experience/Service

Institutional Committee Activities

Consultant, Radiation Oncology Peer Review, MD Anderson Physicians Network, 10/2009-present
Member, India Steering Committee, 9/2008-present
Committee Member, Clinical Research Committee (CRC2), 9/2008-8/2011
Member, Technology Advancement Committee, 6/2007-12/2007
Member, Department of Radiation Oncology Technology Advancement Committee, 2006-present
Member, GYN Patient Care Committee, 2003-present
Chair, Cervix Working Group, 2003-2004
Member, Endometrial Working Group, 2001-present
Member, Cervix Working Group, 2001-present
Director, Radiation Oncology Teaching and Quality Assurance Monthly Staff Meeting, 1997-2007
Member, Utilization Management Committee, 1997-2001
Member, Infection Control Committee, 1996-2001

Honors and Awards

2015 Golden Apple for Mentoring Excellence, Radiation Oncology Resident Class of 2015
2014 America's Top Doctors, Castle Connolly Guides, 8th Edition
2014 Fellow of the American College of Radiology, American College of Radiology
2013 America's Top Doctors, Castle Connolly Guides, 8th Edition
2012 America's Top Doctors, Castle Connolly Guides, 8th Edition
2011 America's Top Doctors for Cancer!, Castle Connolly Medical Ltd.
2011 America's Top Doctors, 10th Ed., Castle Connolly
2010 America's Top Oncologists
2008 America's Top Doctors, Castle Connolly Guides, 8th Edition
2008 RTOG Next Generation Investigator, Radiation Therapy Oncology Group

Professional Memberships

American Association for Women Radiologists
Member, 1996-present
American College of Radiology
Member, ACR Appropriateness Criteria Expert Panel on Radiation Oncology-Gynecology, 5/2009-present
Member, 2002-present
American Medical Association
Member, 1996-present
American Society for Therapeutic Radiology and Oncology
Member, 1994-present
Gynecologic Cancer Intergroup Group
Member, Cervix Working Group, 2006-present
Member, Endometrial Working Group, 2006-present
Gynecologic Oncology Group
Member, Quality of Life Committee, 2002-present
Member, Cervix Committee, 2002-2011
International Gynecologic Cancer Society
Member, 2006-present
National Cancer Institute, Bethesda, MD
Member, Gynecological Cancer Steering Committee Strategic Priorities Core Planning Committee Corpus Team, 1/2015-present
Member, Radiation Oncologist for the Cervical Task Force of the NCI Gynecologic Cancer Steering Committee, 12/2012-11/2015
Society of Gynecologic Oncologists
Member, 2007-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Ho JC, Allen PK, Jhingran A, Westin SN, Lu KH, Eifel PJ, Klopp AH. Management of nodal recurrences of endometrial cancer with IMRT. Gynecol Oncol. e-Pub 7/17/2015. PMID: 26193429.
2. Grant JD, Garg AK, Gopal R, Soliman PT, Jhingran A, Eifel PJ, Klopp AH. Isolated Port-Site Metastases After Minimally Invasive Hysterectomy for Endometrial Cancer: Outcomes of Patients Treated With Radiotherapy. Int J Gynecol Cancer 25(5):869-74, 6/2015. e-Pub 3/18/2015. PMID: 25790043.
3. Salcedo MP, Milbourne AM, Jhingran A, Eifel PJ, Ramirez PT, Schmeler KM. High-grade cervical dysplasia following radiation therapy for invasive cervical cancer: A report of four cases. Case Rep Oncol 8(2):217-21, May-Aug, 5/2015. e-Pub 5/6/2015. PMCID: PMC4464040.
4. Swanick CW, Castle KO, Rechner LA, Rauch GM, Jhingran A, Eifel PJ, Klopp AH. Optimizing packing contrast for MRI-based intracavitary brachytherapy planning for cervical cancer. Brachytherapy 14(3):385-9, May-Jun, 5/2015. e-Pub 1/22/2015. PMID: 25620163.
5. Gómez-Hidalgo NR, Darin MC, Dalton H, Jhingran A, Fleming N, Brown J, Ramirez PT. Ovarian torsion after laparoscopic ovarian transposition in patients with gynecologic cancer: a report of two cases. J Minim Invasive Gynecol 22(4):687-90, May-Jun, 5/2015. e-Pub 3/12/2015. PMID: 25772021.
6. Viswanathan AN, Moughan J, Miller BE, Xiao Y, Jhingran A, Portelance L, Bosch WR, Matulonis UA, Horowitz NS, Mannel RS, Souhami L, Erickson BA, Winter KA, Small W, Gaffney DK. NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer. Cancer. e-Pub 4/6/2015. PMID: 25847373.
7. Thaker NG, Klopp AH, Jhingran A, Frumovitz M, Iyer RB, Eifel PJ. Survival outcomes for patients with stage IVB vulvar cancer with grossly positive pelvic lymph nodes: Time to reconsider the FIGO staging system? Gynecol Oncol 136(2):269-73, 2/2015. e-Pub 12/16/2014. PMCID: PMC4329262.
8. Jhingran A, Kasahara S, Shepardson KM, Junecko BA, Heung LJ, Kumasaka DK, Knoblaugh SE, Lin X, Kazmierczak BI, Reinhart TA, Cramer RA, Hohl TM. Compartment-specific and sequential role of MyD88 and CARD9 in chemokine induction and innate defense during respiratory fungal infection. PLoS Pathog 11(1):e1004589, 1/2015. e-Pub 1/26/2015. PMCID: PMC4306481.
9. Frumovitz M, Jhingran A, Soliman PT, Klopp AH, Schmeler KM, Eifel PJ. Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer. Obstet Gynecol 124(6):1098-104, 12/2014. PMCID: PMC4249728.
10. Viswanathan AN, Erickson B, Gaffney DK, Beriwal S, Bhatia SK, Lee Burnett O, D'Souza DP, Patil N, Haddock MG, Jhingran A, Jones EL, Kunos CA, Lee LJ, Lin LL, Mayr NA, Petersen I, Petric P, Portelance L, Small W, Strauss JB, Townamchai K, Wolfson AH, Yashar CM, Bosch W. Comparison and Consensus Guidelines for Delineation of Clinical Target Volume for CT- and MR-Based Brachytherapy in Locally Advanced Cervical Cancer. Int J Radiat Oncol Biol Phys 90(2):320-8, 10/1/2014. PMCID: PMC4194192.
11. Elshaikh MA, Yashar CM, Wolfson AH, Cardenes HR, Erickson B, Jhingran A, Jolly S, Kidd E, Lee LJ, Mayr NA, Moore D, Rao GG, Small W, Varia MA, Wahl AO, Yuh W, Gaffney DK, Expert Panel on Radiation Oncology-Gynecology:. ACR appropriateness Criteria® advanced stage endometrial cancer. Am J Clin Oncol 37(4):391-6, 8/2014. PMID: 24977691.
12. Sun C, Brown AJ, Jhingran A, Frumovitz M, Ramondetta L, Bodurka DC. Patient preferences for side effects associated with cervical cancer treatment. Int J Gynecol Cancer 24(6):1077-84, 7/2014. PMCID: PMC4287264.
13. Gaffney DK, Jhingran A, Portelance L, Viswanathan A, Schefter T, Weidhaas J, Small W. Radiation Therapy Oncology Group Gynecologic Oncology Working Group: Comprehensive Results. Int J Gynecol Cancer 24(5):956-62, 6/2014. e-Pub 5/9/2014. PMID: 24819663.
14. Basen-Engquist K, Carmack C, Brown J, Jhingran A, Baum G, Song J, Scruggs S, Swartz MC, Cox MG, Lu KH. Response to an exercise intervention after endometrial cancer: Differences between obese and non-obese survivors. Gynecol Oncol 133(1):48-55, 4/2014. PMCID: PMC3979927.
15. Verma J, Sulman EP, Jhingran A, Tucker SL, Rauch GM, Eifel PJ, Klopp AH. Dosimetric Predictors of Duodenal Toxicity After Intensity Modulated Radiation Therapy for Treatment of the Para-aortic Nodes in Gynecologic Cancer. Int J Radiat Oncol Biol Phys 88(2):357-62, 2/1/2014. PMID: 24411609.
16. Frumovitz M, Querleu D, Gil-Moreno A, Morice P, Jhingran A, Munsell MF, Macapinlac HA, Leblanc E, Martinez A, Ramirez PT. Lymphadenectomy in Locally Advanced Cervical Cancer Study (LiLACS): A phase III clinical trial comparing surgical to radiologic staging in patients with stages IB2-IVA cervical cancer. J Minim Invasive Gynecol 21(1):3-8, Jan-Feb, 1/2014. e-Pub 7/31/2013. PMCID: PMC4283493.
17. Tsai CJ, Sulman EP, Eifel PJ, Jhingran A, Allen PK, Deavers MT, Klopp AH. Galectin-7 levels predict radiation response in squamous cell carcinoma of the cervix. Gynecol Oncol 131(3):645-9, 12/2013. e-Pub 4/30/2013. PMID: 23643871.
18. Lee LJ, Jhingran A, Kidd E, Cardenes HR, Elshaikh MA, Erickson B, Mayr NA, Moore D, Puthawala AA, Rao GG, Small W, Varia MA, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Gaffney DK. ACR appropriateness criteria management of vaginal cancer. Oncology (Williston Park) 27(11):1166-73, 11/2013. PMID: 24575547.
19. Likhacheva A, Jhingran A, Bodurka DC, Sun C, Sam M, Eifel PJ. Prospective study of symptom assessment among patients with cervical cancer during concurrent chemoradiotherapy with weekly Cisplatin or every-3-week Cisplatin and 5-Fluorouracil. Int J Gynecol Cancer 23(8):1520-1527, 10/2013. PMID: 24257567.
20. Kidd E, Moore D, Varia MA, Gaffney DK, Elshaikh MA, Erickson B, Jhingran A, Lee LJ, Mayr NA, Puthawala AA, Rao GG, Small W, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Cardenes HR, Expert Panel on Radiation Oncology-Gynecology:. ACR Appropriateness Criteria® Management of Locoregionally Advanced Squamous Cell Carcinoma of the Vulva. Am J Clin Oncol 36(4):415-422, 8/2013. PMID: 23872794.
21. Brown AP, Jhingran A, Klopp AH, Schmeler KM, Ramirez PT, Eifel PJ. Involved-Field Radiation Therapy for Locoregionally Recurrent Ovarian Cancer. Gynecol Oncol 130(2):300-305, 8/2013. e-Pub 5/4/2013. PMCID: PMC4308098.
22. Klopp AH, Moughan J, Portelance L, Miller BE, Salehpour MR, Hildebrandt E, Nuanjing J, D'Souza D, Souhami L, Small W, Gaur R, Jhingran A. Hematologic Toxicity in RTOG 0418: A Phase 2 Study of Postoperative IMRT for Gynecologic Cancer. Int J Radiat Oncol Biol Phys 86(1):83-90, 5/1/2013. PMID: 23582248.
23. Jhingran A, Ramondetta LM, Bodurka DC, Slomovitz BM, Brown J, Levy LB, Garcia ME, Eifel PJ, Lu KH, Burke TW. A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium. Gynecol Oncol 129(2):304-9, 5/2013. e-Pub 2/4/2013. PMID: 23385150.
24. Wagner A, Jhingran A, Gaffney D. Intensity Modulated Radiotherapy in Gynecologic Cancers: Hope, Hype or Hyperbole? Gynecol Oncol. e-Pub 4/2013. PMID: 23632209.
25. Klopp AH, Mourtada F, Yu ZH, Beadle BM, Munsell MF, Jhingran A, Eifel PJ. Pilot study of a computed tomography-compatible shielded intracavitary brachytherapy applicator for treatment of cervical cancer. Pract Radiat Oncol 3(2):115-123, Apr-Jun, 4/2013. e-Pub 5/11/2012. PMID: 24674314.
26. Takiar V, Fontanilla HP, Eifel PJ, Jhingran A, Kelly P, Iyer RB, Levenback CF, Zhang Y, Dong L, Klopp A. Anatomic Distribution of Fluorodeoxyglucose-Avid Para-aortic Lymph Nodes in Patients With Cervical Cancer. Int J Radiat Oncol Biol Phys 85(4):1045-50, 3/15/2013. e-Pub 1/17/2013. PMID: 23332221.
27. Fontanilla HP, Klopp AH, Lindberg ME, Jhingran A, Kelly P, Takiar V, Iyer RB, Levenback CF, Zhang Y, Dong L, Eifel PJ. Anatomic distribution of [(18)F] fluorodeoxyglucose-avid lymph nodes in patients with cervical cancer. Pract Radiat Oncol 3(1):45-53, Jan-Mar, 1/2013. e-Pub 3/30/2012. PMID: 24674263.
28. Fontanilla HP; Kelly P; Jhingran A, Iyer RB, Levenback C, Zhang Y, Dong L, Eifel PJ. Anatomic distribution of FDG-avid paraaortic lymph nodes in patients with cervical cancer. Int J Radiat Oncol Biol Phys. e-Pub 1/2013.
29. Doll CM, Winter K, Gaffney DK, Ryu JK, Jhingran A, Dicker AP, Weidhaas JB, Miller BE, Magliocco AM. COX-2 expression and survival in patients with locally advanced cervical cancer treated with chemoradiotherapy and Celecoxib: A quantitative immunohistochemical analysis of RTOG C0128. Int J Gynecol Cancer 23(1):176-183, 1/2013. PMID: 23221733.
30. Shirvani SM, Klopp AH, Likhacheva A, Jhingran A, Soliman PT, Lu KH, Eifel PJ. Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer. Pract Radiat Oncol 3(1):e21-8, Jan-Mar, 1/2013. e-Pub 5/3/2012. PMID: 24674269.
31. Creutzberg CL, Kitchener HC, Birrer MJ, Landoni F, Lu KH, Powell M, Aghajanian C, Edmondson R, Goodfellow PJ, Quinn M, Salvesen HB, Thomas G [Jhingran A] on behalf of the participants of the second GCIG Endometrial Cancer Clinical Trials Planning Meeting. Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting: Taking Endometrial Cancer Trials Into the Translational Era. Int J Gynecol Ca 23(8):1528-1534, 2013.
32. Jhingran A, Winter K, Portelance L, Miller B, Salehpour M, Gaur R, Souhami L, Small W, Berk L, Gaffney D. A phase II study of intensity-modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: Radiation Therapy Oncology Group trial 0418. Int J Radiat Oncol Biol Phys 84(1):e23-8, 9/1/2012. e-Pub 4/28/2012. PMID: 22543211.
33. Frumovitz M, Ramirez PT, Macapinlac HA, Klopp AH, Nick AM, Ramondetta LM, Jhingran A. Anatomic location of PET-positive aortocaval nodes in patients with locally advanced cervical cancer: Implications for surgical staging. Int J Gynecol Cancer 22(7):1203-7, 9/2012. e-Pub 7/2012. PMCID: PMC4283482.
34. Kelly P, Das P, Varadhachary GR, Fontanilla HP, Krishnan S, Delclos ME, Jhingran A, Eifel PJ, Crane CH. Role of definitive radiation therapy in carcinoma of unknown primary in the abdomen and pelvis. Int J Radiat Oncol Biol Phys 82(5):2012-7, 4/1/2012. e-Pub 6/2/2011. PMID: 21640510.
35. Gay HA, Barthold HJ, O'Meara E, Bosch WR, El Naqa I, Al-Lozi R, Rosenthal SA, Lawton C, Lee WR, Sandler H, Zietman A, Myerson R, Dawson LA, Willett C, Kachnic LA, Jhingran A, Portelance L, Ryu J, Small W Jr, Gaffney D, Viswanathan AN, Michalski JM. Pelvic normal tissue contouring guidelines for radiation therapy: A Radiation Therapy Oncology Group consensus panel atlas. Int J Radiat Oncol Biol Phys. e-Pub 4/2012. PMID: 22483697.
36. Jhingran A, Salehpour M, Sam M, Levy L, Eifel PJ. Vaginal motion and bladder and rectal volumes during pelvic intensity-modulated radiation therapy after hysterectomy. Int J Radiat Oncol Biol Phys 82(1):256-62, 1/1/2012. e-Pub 11/17/2010. PMID: 21093170.
37. Small W Jr, Strauss JB, Jhingran A, Yashar CM, Cardenes HR, Erickson-Wittmann BA, Gullett N, Kidd E, Lee LJ, Mayr NA, Moore D, Puthawala AA, Rao GG, Varia MA, Wahl AO, Wolfson AH, Yuh W, Gaffney DK. ACR Appropriateness Criteria® definitive therapy for early-stage cervical cancer. Am J Clin Oncol 35(4):399-405, 2012. PMID: 22810416.
38. Faro JP, Graybill WS, Tung CS, Jhingran A, Ramirez PT, Schmeler KM. Small bowel perforation 17 months after robotic surgery for endometrial cancer: A case report. Gynecol Oncol Reports 2:9-10, 2012.
39. Wolfson AH, Varia MA, Moore D, Rao GG, Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Small, Jr. W, Yashar CM, Yuh W, Cardenes HR. ACR Appropriateness Criteria® role of adjuvant therapy in the management of early stage cervical cancer. International Journal of Gynecological Cancer. e-Pub 12/2011. PMID: 22155418.
40. Fisher CM, Fortenberry BR, Jhingran A, Eifel PJ. Novel technique for simulation and external beam treatment planning for obese patients. Pract Radiat Oncol 1(3):152-155, Jul-Sep, 7/2011. e-Pub 5/6/2011. PMID: 24673944.
41. Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Moore D, Rao GG, Small W, Varia MA, Wolfson AH, Yashar CM, Yuh W, Cardenes HR. ACR Appropriateness Criteria® on advanced cervical cancer expert panel on radiation oncology-gynecology. Int J Radiat Oncol Biol Phys. e-Pub 1/2011. PMID: 21215531.
42. Lee JH, Dubinsky T, Andreotti RF, Cardenes HR, Dejesus Allison SO, Gaffney DK, Glanc P, Horowitz NS, Jhingran A, Lee SI, Puthawala AA, Royal HD, Scoutt LM, Small W Jr, Varia MA, Zelop CM; and Expert Panel on Women's Imaging and Radiation Oncology-Gynecology. ACR Appropriateness Criteria® pretreatment evaluation and follow-up of endometrial cancer of the uterus. Ultrasound Q 27(2):139-145, 2011. PMID: 21606818.
43. Small W, Winter K, Levenback C, Iyer R, Hymes SR, Jhingran A, Gaffney D, Erickson B, Greven K. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin and amifostine for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of arm II of RTOG 0116. Int J Gynecol Ca 21(7):1266-1275, 2011. PMID: 21892091.
44. Sharp HJ, Pinnix CC, Jhingran A, Euscher ED, Rohren EM, Ramirez PT. PET/CT in a patient with adenoma malignum of the uterine cervix. Clin Nucl Med 36(6):468-469, 2011. PMID: 21552028.
45. Faro JP, Graybill WS, Tung CS, Jhingran A, Ramirez PT, Schmeler KM. Small bowel perforation 17 months after robotic surgery for endometrial cancer: A case report. Gynecol Oncol Case Rep 2(1):9-10, 2011. e-Pub 11/20/2011. PMCID: PMC3860727.
46. Garg AK, Jhingran A, Klopp AH, Aggarwal BB, Kunnumakkara AB, Broadus RR, Eifel PJ, Buchholz TA. Expression of nuclear transcription factor Kappa B in locally advanced human cervical cancer treated with definitive chemoradiation. Int J Radiat Oncol Biol Phys 78(5):1331-6, 12/2010. e-Pub 3/2010. PMID: 20231067.
47. Zand B, Euscher ED, Soliman PT, Schmeler KM, Coleman RL, Frumovitz M, Jhingran A, Ramondetta LM, Ramirez PT. Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer. Gynecol Oncol 119(3):422-5, 12/2010. e-Pub 9/2010. PMID: 20837355.
48. Ramirez PT, Jhingran A, Macapinlac HA, Euscher ED, Munsell MF, Coleman RL, Soliman PT, Schmeler KM, Frumovitz M, Ramondetta LM. Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: A prospective correlation of surgical findings with positron emission tomography/computed tomography findings. Cancer 117(9). e-Pub 11/2010. PMID: 21509770.
49. Lim K, Small W, Portelance L, Creutzberg C, Jürgenliemk-Schulz IM, Mundt A, Mell LK, Mayr N, Viswanathan A, Jhingran A, Erickson B, De Los Santos J, Gaffney D, Yashar C, Beriwal S, Wolfson A, Taylor A, Bosch W, El Naqa I, Fyles A, Gyn IMRT Consortium.. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys. e-Pub 5/2010. PMID: 20472347.
50. Beadle BM, Jhingran A, Yom SS, Ramirez PT, Eifel PJ. Patterns of regional recurrence after definitive radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 76(5):1396-403, 4/2010. e-Pub 7/2009. PMID: 19581056.
51. Schmeler KM, Jhingran A, Iyer RB, Sun CC, Eifel PJ, Soliman PT, Ramirez PT, Frumovitz M, Bodurka DC, Sood AK. Pelvic fractures after radiotherapy for cervical cancer: Implications for survivors. Cancer 116(3):625-630, 2/2010. e-Pub 1/2010. PMID: 20052724.
52. Klopp AH, Jhingran A, Ramondetta L, Lu K, Gershenson DM, Eifel PJ. Node-positive adenocarcinoma of the endometrium: Outcome and patterns of recurrence with and without external beam irradiation. Gynecol Oncol 115(1):6-11, 10/2009. e-Pub 7/25/2009. PMID: 19632709.
53. Hunter RJ, Pace MB, Burns KA, Burke CC, Gonzales DA, Webb NF, Levenback CF, Jhingran A, Parker C, Munsell MF, Smith JA. Evaluation of intervention to prevent hypomagnesaemia in cervical cancer patients receiving combination cisplatin and radiation treatment. Support Care Cancer 17(9):1195-201, 9/2009. e-Pub 1/2009. PMID: 19172305.
54. Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ. Concurrent chemoradiation in the routine management of patients with cervical cancer: Does marital status matter? Int J Gynecol Cancer 19(6):1107-12, 8/2009. PMID: 19820377.
55. Weidhaas JB, Li SX, Winter K, Ryu J, Jhingran A, Miller B, Dicker AP, Gaffney D. Changes in gene expression predicting local control in cervix cancer: Results from RTOG 0128. Clin Cancer Res 15(12):4199-4206, 6/2009. e-Pub 6/2009. PMCID: PMC2758917.
56. Basen-Engquist K, Scruggs S, Jhingran A, Bodurka DC, Lu K, Ramondetta L, Hughes D, Carmack Taylor C. Physical activity and obesity in endometrial cancer survivors: Associations with pain, fatigue, and physical functioning. Am J Obstet Gynecol 200(3):288.e1-8, 3/2009. e-Pub 12/2008. PMCID: PMC2666540.
57. Beadle BM, Jhingran A, Salehpour M, Sam M, Iyer RB, Eifel PJ. Cervix regression and motion during the course of external beam chemoradiation for cervical cancer. Int J Radiat Oncol Biol Phys 73(1):235-41, 1/2009. e-Pub 5/2008. PMID: 18513882.
58. Eifel PJ, Jhingran A, Levenback CF, Tucker S. Predictive value of a proposed subclassification of stages I and II cervical cancer based on clinical tumor diameter. Int J Gynecol Cancer 19(1):2-7, 1/2009. PMID: 19258933.
59. Kitchener HC, Trimble EL, Endometrial Cancer Working Group of the Gynecologic Cancer Intergroup. Endometrial cancer state of the science meeting. Int J Gynecol Cancer 19(1):134-140, 2009. PMID: 19258955.
60. Frumovitz M, Sun CC, Jhingran A, Schmeler KM, Dos Reis R, Milam MR, Soliman PT, Taylor K, Ramirez PT. Radical hysterectomy in obese and morbidly obese women with cervical cancer. Obstet Gynecol 112(4):899-905, 10/2008. PMID: 18827134.
61. Small W, Mell LK, Anderson P, Creutzberg C, De Los Santos J, Gaffney D, Jhingran A, Portelance L, Schefter T, Iyer R, Varia M, Winter K, Mundt AJ. Consensus guidelines for the delineation of the clinical target volume for intensity modulated pelvic radiotherapy in the postoperative treatment of endometrial cancer. Int J Radiat Oncol Biol Phys 71(2):428-434, 6/2008. e-Pub 11/2007. PMID: 18037584.
62. Klopp AH, Jhingran A, Ramdas L, Story MD, Broadus RR, Lu KH, Eifel PJ, Buchholz TA. Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcome. Int J Radiat Oncol Biol Phys 71(1):226-36, 5/2008. PMID: 18406887.
63. Frumovitz M, Gayed IW, Jhingran A, Euscher ED, Coleman RL, Ramirez PT, Levenback CF. Lymphatic mapping and sentinel lymph node detection in women with vaginal cancer. Gynecol Oncol 108(3):478-481, 3/2008. e-Pub 1/2008. PMID: 18190952.
64. Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ. Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment. Int J Radiat Oncol Biol Phys 70(1):118-25, 1/2008. e-Pub 9/2007. PMID: 17869451.
65. Ramondetta LM, Jhingran A. Eleven years: The long and winding road. Gynecol Oncol 107(2):166-168, 11/2007. PMID: 17950382.
66. Small W, Winter K, Levenback C, Iyer R, Gaffney D, Asbell S, Erickson B, Jhingran A, Greven K. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: Results of ARM 1 of RTOG 0116. Int J Radiat Oncol Biol Phys 68(4):1081-1087, 7/2007. e-Pub 2007. PMID: 17398031.
67. Frank SJ, Deavers MT, Jhingran A, Bodurka DC, Eifel PJ. Primary adenocarcinoma of the vagina not associated with diethylstilbestrol (DES) exposure. Gynecol Oncol 105(2):470-479, 2007. e-Pub 2007. PMID: 17292459.
68. Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos S, Cho KR, Copeland L, Eifel P, Jaggernauth W, Jhingran A, Kapp DS, Kavanagh J, Lipscomb GH, Lurain JR, Morgan RJ, Nag S, Partridge EE, Powell CB, Remmenga SW, Reynolds RK, Small W, Soper J, Teng N, National Comprehensive Cancer Network. Uterine cancers. J Natl Compr Canc Netw 4(5):438-62, 5/2006. PMID: 16687093.
69. Ramondetta LM, Sun C, Hollier L, Jarrett L, Folloder J, Tortolero-Luna G, Hughes A, Jhingran A, Brown J. Advanced cervical cancer treatment in Harris County: Pilot evaluation of factors that prevent optimal therapy. Gynecol Oncol 103(2):547-53, 2006. e-Pub 5/2006. PMID: 16730784.
70. Iyer R, Jhingran A. Radiation injury: Imaging findings in the chest, abdomen and pelvis after therapeutic radiation. Cancer Imaging 31(6):S131-9, 2006. e-Pub 10/31/2006. PMCID: PMC1805064.
71. Zighelboim I, Ramirez PT, Gao F, Slomovitz BM, Sun C, Frumovitz M, Jhingran A, Levenback C. Retroperitoneal lymph node resection in patients with cervical cancer. Surg Oncol 15(2):79-83, 2006. e-Pub 10/2006. PMID: 17035002.
72. Eifel PJ, Jhingran A, Brown J, Levenback C, Thames H. Time course and outcome of central recurrence after radiation therapy for carcinoma of the cervix. Int J Gynecol Cancer 16(3):1106-11, May-Jun, 2006. PMID: 16803493.
73. Strom EA, Woodward WA, Katz A, Buchholz TA, Perkins GH, Jhingran A, Theriault R, Singletary E, Sahin A, McNeese MD. Clinical investigation: Regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys 63(5):1508-13, 12/1/2005. e-Pub 9/19/2005. PMID: 16169678.
74. Price MJ, Horton JL, Gifford KA, Eifel PJ, Jhingran A, Lawyer AA, Berner PA, Mourtada F. Dosimetric evaluation of the Fletcher-Williamson ovoid for pulsed-dose-rate brachytherapy: A Monte Carlo study. Phys Med Biol 50(21):5075-87, 11/7/2005. e-Pub 10/19/2005. PMID: 16237242.
75. Gifford KA, Horton JL, Pelloski CE, Jhingran A, Court LE, Mourtada F, Eifel PJ. A three-dimensional computed tomography-assisted Monte Carlo evaluation of ovoid shielding on the dose to the bladder and rectum in intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 63(2):615-21, 10/1/2005. PMID: 16168853.
76. Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, Eifel P, Bevers TB, Levenback CF, Gershenson DM, Bodurka DC. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol 23(30):7428-36, 10/20/2005. PMID: 16234510.
77. Solin LJ, Fourquet A, Vicini FA, Taylor M, Haffty B, Strom EA, Wai E, Pierce LJ, Marks LB, Bartelink H, Campana F, McNeese MD, Jhingran A, Olivotto IA, Bijker N, Hwang WT. Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ. Eur J Cancer 41(12):1715-23, 8/2005. PMID: 16043350.
78. Ahamad A, D'Souza W, Salehpour M, Iyer R, Tucker SL, Jhingran A, Eifel PJ. Intensity-modulated radiation therapy after hysterectomy: Comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size. Int J Radiat Oncol Biol Phys 62(4):1117-24, 7/15/2005. PMID: 15990017.
79. Pelloski CE, Palmer M, Chronowski GM, Jhingran A, Horton J, Eifel PJ. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 62(1):131-7, 5/1/2005. PMID: 15850913.
80. Frank SJ, Jhingran A, Levenback C, Eifel PJ. Definitive radiation therapy for squamous cell carcinoma of the vagina. Int J Radiat Oncol Biol Phys 62(1):138-47, 5/2005. PMID: 15850914.
81. D'Souza WD, Ahamad AA, Iyer RB, Salehpour MR, Jhingran A, Eifel PJ. Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma. Int J Radiat Oncol Biol Phys 61(4):1062-1070, 3/15/2005. PMID: 15752885.
82. Solin LJ, Fourquet A, Vicini FA, Taylor M, Olivotto IA, Haffty B, Strom EA, Pierce LJ, Marks LB, Bartelink H, McNeese MD, Jhingran A, Wai E, Bijker N, Campana F, Hwang WT. Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer 103(6):1137-46, 3/15/2005. PMID: 15674853.
83. Tangjitgamol S, Ramirez PT, Sun CC, See HT, Jhingran A, Kavanagh JJ, Deavers MT. Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study. Int J Gynecol Cancer 15(4):646-56, Jul-Aug, 2005. PMID: 16014119.
84. Slomovitz BM, Ramondetta LM, Lee CM, Oh JC, Eifel PJ, Jhingran A, Burke TW, Gershenson DM, Lu KH. Heterogeneity of stage IIIA endometrial carcinomas: Implications for adjuvant therapy. Int J Gynecol Cancer 15(3):510-6, May-Jun, 2005. PMID: 15882178.
85. Viswanathan AN, Deavers MT, Jhingran A, Ramirez PT, Levenback C, Eifel PJ. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol 93(1):27-33, 4/2004. PMID: 15047210.
86. Callister M, Ramondetta LM, Jhingran A, Burke TW, Eifel PJ. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome. Int J Radiat Oncol Biol Phys 58(3):786-96, 3/1/2004. PMID: 14967435.
87. Slomovitz BM, Burke TW, Eifel PJ, Ramondetta LM, Silva EG, Jhingran A, Oh JC, Atkinson EN, Broaddus RR, Gershenson DM, Lu KH. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol 91(3):463-9, 12/2003. PMID: 14675663.
88. Stehman FB, Rose PG, Greer BE, Roy M, Plante M, Penalver M, Jhingran A, Eifel P, Montz F, Wharton JT. Innovations in the treatment of invasive cervical cancer. Cancer 98(Suppl 9):2052-2063, 11/1/2003. PMID: 14603542.
89. Katz A, Eifel PJ, Jhingran A, Levenback CF. The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva. Int J Radiat Oncol Biol Phys 57(2):409-18, 10/2003. PMID: 12957252.
90. Ramondetta LM, Burke TW, Jhingran A, Schmandt R, Bevers MW, Wolf JK, Levenback CF, Broaddus R. A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed müllerian tumors with evaluation of potential molecular targets. Gynecol Oncol 90(3):529-36, 9/2003. PMID: 13678720.
91. Gordinier ME, Malpica A, Burke TW, Bodurka DC, Wolf JK, Jhingran A, Ramirez PT, Levenback C. Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol Oncol 90(3):625-8, 9/2003. PMID: 13678736.
92. Jhingran A, Burke TW, Eifel PJ. Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy. Int J Radiat Oncol Biol Phys 56(5):1366-72, 8/1/2003. PMID: 12873682.
93. Kabbani W, Deavers MT, Malpica A, Burke TW, Liu J, Ordoñez NG, Jhingran A, Silva EG. Uterine tumor resembling ovarian sex-cord tumor: report of a case mimicking cervical adenocarcinoma. Int J Gynecol Pathol 22(3):297-302, 7/2003. PMID: 12819400.
94. Buchholz TA, Davis DW, McConkey DJ, Symmans WF, Valero V, Jhingran A, Tucker SL, Pusztai L, Cristofanilli M, Esteva FJ, Hortobagyi GN, Sahin AA. Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy. Cancer J 9(1):33-41, Jan-Feb, 1/2003. PMID: 12602766.
95. Jhingran A, Kim JS, Buchholz TA, Katz A, Strom EA, Hunt KK, Sneige N, McNeese MD. Age as a predictor of outcome for women with DCIS treated with breast-conserving surgery and radiation: The University of Texas MD Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 54(3):804-9, 11/1/2002. PMID: 12377332.
96. Munkarah AR, Jhingran A, Iyer RB, Wallace S, Eifel PJ, Gershenson D, Burke TW. Utility of lymphangiography in the prediction of lymph node metastases in patients with cervical cancer. Int J Gynecol Cancer 12(6):755-9, Nov-Dec, 11/2002. PMID: 12445255.
97. Eifel PJ, Jhingran A, Bodurka DC, Levenback C, Thames H. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol 20(17):3651-7, 9/1/2002. PMID: 12202666.
98. Iyer RB, Jhingran A, Sawaf H, Libshitz HI. Imaging findings after radiotherapy to the pelvis. AJR Am J Roentgenol 177(5):1083-9, 2001. PMID: 11641175.
99. Katz A, Strom EA, Buchholz TA, Thames HD, Smith CD, Jhingran A, Hortobagyi G, Buzdar AU, Theriault R, Singletary SE, McNeese MD. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 18(15):2817-27, 8/2000. PMID: 10920129.
100. Buchholz TA, Tucker SL, Moore RA, McNeese MD, Strom EA, Jhingran A, Hotobagyi GN, Singletary SE, Champlin RE. Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and stem cell transplant. Int J Radiat Oncol Biol Phys 46(2):337-343, 2000.
101. Verstovsek S, Verschraegen CF, Edwards CL, Malpica A, Kavanagh JJ, Ross MI, Strom EA, Jhingran A, Theriault RL, Kudelka AP. Synchronous primary cancers of the breast and cervix: planning multidisciplinary primary treatment [clinico-pathological conference]. Am J Clin Oncol 23(1):99-103, 2000. PMID: 10683089.
102. Hogberg T, Fredstorp M, Jhingran A. Indications for adjuvant radiotherapy in endometrial carcinoma. Hematol Oncol Clin North Am 13(1):189-209, 1999. PMID: 10080076.

Invited Articles

1. Jeffery DD, BarberaL, Andersen BL, Siston AK, Jhingran A, Baron SR, Reese JB, Coady DJ, Carter J, Flynn KE. Self-reported sexual function measures administered to female cancer patients: A systemic review 2008-2014. Journal of Psychosocial Oncology, http://www.tandfonline.com/doi/full/10.1080/07347332.2015.1046012., 5/2015.
2. Frumovitz M, Jhingran A, Schmeler KM. Early-stage cervical cancer: Treatment choices vary according to disease stage and patient-specific factors. OncoLog 57(7), 7/2012.
3. Bhosale P, Iyer R, Jhingran A, Podoloff D. PET/CT imaging in gynecologic malignancies other than ovarian and cervical cancer. PET Clinics 5(4):463-475, 10/2010.
4. Jhingran A. Technical advances in radiation oncology for the treatment of cervical carcinoma. Revista de Ginecologia Oncologica 3:18-26, 11/2008.
5. Jhingran A. Potential advantages of intensity-modulated radiation therapy in gynecologic malignancies. Semin Radiat Oncol 16(3):144-51, 7/2006. PMID: 16814154.
6. Jhingran A. The Shivnani/Rimel/Schink/Small article reviewed: Cancer of the cervix: Current management and new approaches. Oncology 20(12):3, 2006.
7. Ahamad A, Jhingran A. New radiation techniques in gynecological cancer. Int J Gynecol Cancer 14(4):569-79, Jul-Aug, 7/2004. PMID: 15304149.

Book Chapters

1. Jhingran A, Burke T. Cervix. In: MD Anderson Cancer Center Survival Monograph. In Press.
2. Jhingran A, Russell AH, Seiden MV, Duska LR, Goodman AK, Lee SI, Digumarthy SR, Fuller Jr AF. Cancers of the cervix, Vulva, and Vagina. In: Clinical Oncology, 5th. Ed(s) Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE. Elsevier Churchill Livingstone: Philadelphia, PA, 1534-1574, 2013.
3. Burke TW, Jhingran A, Lu K, and Broaddus R. Endometrial Cancer. In: 60 years of survival outcomes at the University of Texas MD Anderson Cancer Center. Ed(s) Rodriguez MA, Walters RS, Burke TW. Springer: New York, 109-117, 2013. ISBN: 978-4614-5196-9.
4. Jhingran A, Shaaban AM. Ovary and Fallopian Tube. In: Radiation Oncology Imaging and Treatment, 1st. Ed(s) Gaffney DK, Shrieve D, Anker CJ, Buyyounouski MK, Kong FM, Hitchcock YJ, Tward JD. Amirsys Publishing, Inc. Canada, 54-75, 2013. ISBN: 978-1-931884-70-9.
5. Klopp A, Jhingran A. Field cancerization in vulvar, vaginal, and cervical epithelia. In: Field Cancerization: Basic Science and Clinical Applications. Ed(s) Dakubo GD. Nova Science Publishers, Inc. New York, 415-421, 2011. ISBN: 978-1-61761-006-6.
6. Jhingran A. Neoplasms of the cervix. In: Cancer Medicine, 8th. Ed(s) WK Hong, RC Bast Jr., WN Hait, DW Kufe, RE Pollock, RR Weichselbaum, JF Holland, E Frei III. People's Medical Publishing House - USA: Shelton, CT, 1299-1324, 2010. ISBN: 978-1-60795-014-1.
7. Jhingran A, Eifel PJ. The endometrium. In: Radiation Oncology, 9th. Ed(s) JD Cox, KK Ang. Mosby: St. Louis, MO, 774-797, 2010. ISBN: 978-0-323-04971-9.
8. Jhingran A. The ovary. In: Radiation Oncology, 9th. Ed(s) JD Cox, KK Ang. Mosby: St. Louis, MO, 812-832, 2010. ISBN: 978-0-323-04971-9.
9. Jhingran A, Eifel PJ. Radiation therapy for cervical carcinoma. In: Gynecology & Obstetrics. Global Library of Women's Medicine, http://www.glowm.com/index.html?p=glowm.cml/section_view&articleid=234&recordset=Search%20results&value=, e-Book 2008.
10. Jhingran A, Levenback C. Malignant diseases of the cervix. In: Comprehensive Gynecology, 5th. Ed(s) VL Katz, GM Lentz, RA Lobo, DM Gershenson. Mosby: Philadelphia,PA, 759-780, 2007.
11. Jhingran A. Predictors of radiation sensitivity and resistance. In: Prognostic and Predictive Factors in Gynecologic Cancer. Ed(s) C Levenback, A Sood, K Lu, R LColeman,. Taylor & Francis Medical Books: United Kingdom, 259-267, 2007.
12. Jhingran A, Eifel PJ, Wharton JT, Totolero-Luna G. Neoplasms of the cervix. In: Cancer Medicine, 7th. Ed(s) DW Kufe, RC Bast Jr, WN Hait, WK Hong, RE Pollock, RR Weichselbaum, JF Holland, E Frei III. BC Decker Inc. Hamilton, London, 1497-1521, 2006. ISBN: 1-55009-307-X.
13. Brown J, Jhingran A, Deavers M, Markman M. Stromal tumors of the ovary. In: Textbook of Uncommon Cancer, 3rd. Ed(s) D Raghavan, ML Brecher, DH Johnson, NJ Meropol, PL Moots, PG Rose, IA Mayer. John Wiley and Sons, Ltd: West Sussex UK, 455-466, 2006.
14. Ramondetta LM, Burke TW, Broaddus R, Jhingran A. Treatment of endometrial cancer. In: Gynecologic Cancer, MD Anderson Cancer Care Series. Ed(s) AU Buzdar, RS Freedman. Springer-Verlag: New York, 148-174, 2006.
15. Jhingran A, Eifel PJ, Ramirez PT. Treatment of locally advanced cervical cancer. In: Gynecologic Cancer, MD Anderson Cancer Care Series. Ed(s) AU Buzdar, RS Freedman. Springer-Verlag: New York, 102-124, 2006.
16. Ramondetta LM, Bodurka DC, Deavers MT, Jhingran A. Uterine sarcomas. In: Gynecologic Cancer, MD Anderson Cancer Care Series. Ed(s) AU Buzdar, RS Freedman. Springer-Verlag: New York, 125-147, 2006.
17. Jhingran A, Salehpour M, Brooks B. Endometrial cancer. In: Intensity Modulated Radiation Therapy: A Clinical Perspective. Ed(s) AJ Mundt, JC Roeske. BC Decker: Philadelphia, 513-517, 2005.
18. Jhingran A. Gynecologic cancers. In: Practical Essential of Intensity Modulated Radiation Therap. Ed(s) KSC Chao, S Apisarnthanarax, G Ozyigit. Lippincott Williams and Wilkins: Philadelphia, 325-351, 2005.
19. Jhingran A, Eifel PJ. Cancer of the endometrium. In: Radiation Oncology, 8th. Ed(s) JD Cox, KK Ang. Mosby: St. Louis MO, 724-742, 2003.
20. Jhingran A, Eifel PJ, Wharton JT, Tortolero-Luna G. Neoplasms of the cervix. In: Cancer Medicine. 2, 6th. Ed(s) Holland and Frei. B. C. Decker, Inc. Ontario, 1779-1808, 2003.
21. Jhingran A, Eifel PJ. Radiation therapy. In: Handbook of Gynecologic Oncology. Ed(s) RR Bakarat, MW Bevers, DM Gershenson, WJ Hoskins. Martin Dunitz Ltd. London, 77-90, 2002.
22. Jhingran A, Eifel PJ. Radiation therapy for invasive cervical cancer. In: ACS Atlas of Oncology: Cervix, Vulva and Vagina. Ed(s) PJ Eifel, C Levenback. B. C. Decker, Inc. Ontario, 147-168, 2001.
23. Jhingran A, Eifel PJ. Radiotherapy. In: Gynecologic Oncology Handbook. Ed(s) RR Bakarat, MW Bevers, DM Gershenson, WJ Hoskins. Martin Dunitz Ltd. London, 73-87, 2000.
24. Jhingran A, Eifel PJ. The role of radiotherapy in the management of vulvar cancer. In: Cancer and Precancer of the Vulva. Ed(s) D Luesley. Thomson Science & Professional: London, 120-134, 2000.
25. Jhingran A. Radiation treatment of cervical cancer. In: Cervical Cancer. Future Science Group: United Kingdom. Submitted.

Grant & Contract Support

Title: Inverse Planning Software for Adaptive Intracavitary Brachytherapy
Funding Source: MDACC Technical Review Committee
Role: Co-Investigator
Principal Investigator: Mourtada
Duration: 10/2006 - 6/2007
 
Title: Validation of prognostic gene set associated with recurrence following chemoradiation in cervical cancer
Funding Source: RTOG
Role: Principal Investigator
Duration: 4/2006 - 5/2007
 
Title: Social Cognitive Theory and PA after Endometrial Cancer
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: Basen-Engquist
Duration: 9/2004 - 8/2009
 
Title: Adaptive Intracavitary Brachytherapy Applicator for Cervical Cancer
Funding Source: MD Anderson Technology Review Committee, Office of Protocol Research
Role: Co-Principal Investigator
Principal Investigator: Mourtada/Eifel
Duration: 7/2004 - 9/2005
 
Title: U10 Full Member Application Affiliated with SWOG
Funding Source: SWOG
Role: Investigator
Principal Investigator: Scott Lippman, M.D.
Duration: 1/2004 - 1/2009
 
Title: Sexual Functioning and Quality Of Life in Women with Cervical Cancer
Funding Source: NIH/NIAMS
Role: Co-Program Leader
Principal Investigator: Diane Bodurka, M.D.
Duration: 1/2003 - 1/2006
 
Title: NCI Grant Supporting Cancer Disparities Grant Collaboration MD Anderson and Mercy Health Center Laredo
Funding Source: NIH/NCI
Role: Co-Program Leader
Principal Investigator: Jhingran/Baines
Duration: 10/2002 - 8/2003

Last updated: 9/21/2015